BRAF and thyroid gland carcinoma: The thyroid cancer progression hypothesis is corroborated by a transgenic mouse model for the early activation of the BRAFT1799A oncogene restricted to the thyroid gland (Tg-BRAF) that is affected by high penetrance PTC that undergoes temporal dedifferentiation [13].